Reglan and Pulmonary haemorrhage - a phase IV clinical study of FDA data

Summary:

Pulmonary haemorrhage is reported as a side effect among people who take Reglan (metoclopramide hydrochloride), especially for people who are male, 50-59 old, have been taking the drug for < 1 month also take Vicodin, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Pulmonary haemorrhage when taking Reglan. It is created by eHealthMe based on reports of 28,854 people who have side effects when taking Reglan from the FDA, and is updated regularly.

What is Reglan?

Reglan has active ingredients of metoclopramide hydrochloride. It is often used in gastroparesis. eHealthMe is studying from 29,455 Reglan users. Check the latest studies of Reglan.

What is Pulmonary haemorrhage?

Pulmonary haemorrhage (acute bleeding from the lung) is found to be associated with 776 drugs and 935 conditions by eHealthMe. Check the latest studies of Pulmonary haemorrhage.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 28, 2026

28,854 people reported to have side effects when taking Reglan.
Among them, 28 people (0.1%) have Pulmonary haemorrhage.

Could Reglan cause Pulmonary haemorrhage?

Among these 28 people:

How long have people been on Reglan when they have Pulmonary haemorrhage? *

What is the gender of people who have Pulmonary haemorrhage when taking Reglan? *

female: 42.86 %
male: 57.14 %

What is the age of people who have Pulmonary haemorrhage when taking Reglan? *

What are other drugs people take besides Reglan? *

What are other side effects people have besides Pulmonary haemorrhage? *

Pneumonia: 15 people, 53.57%
Hypotension (abnormally low blood pressure): 14 people, 50.00%
Coughing Up Blood: 14 people, 50.00%
Fever: 14 people, 50.00%
Enlarged Heart: 13 people, 46.43%
Cough: 13 people, 46.43%
Heart Attack: 13 people, 46.43%
Anaemia (lack of blood): 10 people, 35.71%
Atelectasis (partial or complete collapse of the lung): 10 people, 35.71%
Haematuria (presence of blood in urine): 10 people, 35.71%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 11 people, 39.29%
Pain: 6 people, 21.43%
Obstructive Airways Disorder (a progressive disease that makes it hard to breathe): 4 people, 14.29%
Constipation: 4 people, 14.29%
Depression: 4 people, 14.29%
Gastrointestinal Motility Disorder (abnormal intestinal contractions): 4 people, 14.29%
Inflammation: 4 people, 14.29%
Wheezing (a high-pitched whistling sound made while you breath): 4 people, 14.29%
Pseudomonas Infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa): 4 people, 14.29%
Rhinitis (a medical term for irritation and inflammation of the mucous membrane inside the nose): 4 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Reglan and have Pulmonary haemorrhage?

- Check whether Pulmonary haemorrhage is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Reglan:

Reglan (29,455 reports)

Browse all side effects of Reglan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pulmonary haemorrhage:

Pulmonary haemorrhage (776 drugs)

Browse all the conditions that are associated with Pulmonary haemorrhage:

Pulmonary haemorrhage (935 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on metoclopramide hydrochloride (the active ingredients of Reglan) and Reglan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.